Cargando…
Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial
PURPOSE: To compare the efficacy and tolerability of a fixed-dose combination of 0.5% moxifloxacin and 0.1% dexamethasone formulation (MFLX/DEX) vs conventional dosing with both agents dosed separately for prophylaxis after laser-assisted in situ keratomileusis (LASIK). METHODS: A prospective, rando...
Autores principales: | Campos, Mauro, Ávila, Mariana, Wallau, Anelise, Muccioli, Cristina, Höfling-Lima, Ana Luisa, Belfort, Rubens |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693985/ https://www.ncbi.nlm.nih.gov/pubmed/19668724 |
Ejemplares similares
-
Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK
por: Campos, Mauro, et al.
Publicado: (2011) -
Efficacy and Tolerability of a Combined Moxifloxacin/Dexamethasone Formulation for Topical Prophylaxis in Phacoemulsification: An Open-Label Single-Arm Clinical Trial
por: Espiritu, Cesar Ramon G., et al.
Publicado: (2011) -
Acute iris depigmentation following systemic moxifloxacin
por: do Nascimento, Heloisa Moraes, et al.
Publicado: (2013) -
Subconjunctival dexamethasone implant for non-necrotizing scleritis
por: Nascimento, Heloisa, et al.
Publicado: (2013) -
One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with mitomycin C and LASIK
por: Wallau, A D, et al.
Publicado: (2009)